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Introduction
Dermatofibrosarcoma protuberans (DFSP) is a fibrohistio-
cytic tumor that arises from the dermis and invades deeper 
tissue [1,2]. Classic DFSP clinically appears as an indurated 
plaque or nodule, exhibiting flesh to reddish brown color [1]. 
The tumor is locally aggressive and has a high rate of recur-
rence; however, it rarely metastasizes [1,2]. The diagnosis of 
DFSP is often delayed because of its rarity, slow progression, 
and lack of early clinical clues. Therefore, dermoscopy may 
be a valuable tool in the recognition and prompt diagnosis of 
this tumor. Few previous reports have addressed the dermo-
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Background: Dermatofibrosarcoma protuberans (DFSP) is an uncommon mesenchymal tumor of in-
termediate malignancy. Its rarity and slow progression often imply a delayed diagnosis. There are few 
previous reports of dermoscopic features of DFSP and most are single case descriptions.
Objectives: To report 2 cases of DFSP and their dermoscopic features, as well as conduct a review of 
all previous cases published addressing the use of dermoscopy in this tumor.
Methods: We conducted a literature search for all dermoscopic cases of DFSP. In addition, we pre-
sented 2 additional cases and compared them to the earlier findings.
Results: We summarized the main dermoscopic findings of DFSP based on analysis from 32 patients. 
The most common features of this tumor are the presence of vessels (81%), followed by a pigmented 
network (78%) and a pinkish background (66%).
Conclusions: DFSP can mimic benign lesions and the diagnosis may be challenging. Dermoscopy is an 
important tool that may enhance clinical suspicion toward the diagnosis of DFSP.
ABSTRACT
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tasis. The lesion was totally excised with 3-cm margins and 
there has been no recurrence in 2 years of follow-up.
Patient 2
A 50-year-old woman, Fitzpatrick skin phototype IV, was 
referred to the dermatology department to evaluate the pos-
sibility of Cowden syndrome, since she had been previously 
diagnosed with breast cancer and papillary thyroid carcinoma. 
After a thorough physical examination, the patient did not 
meet the clinical diagnostic criteria for the syndrome. How-
ever, an inframammary brownish plaque lesion was observed. 
There was no history of trauma or previous procedures to the 
area. The patient had noticed a gradual enlargement of the 
lesion in the preceding 2 years. Physical examination showed 
a brown atrophic plaque on the left inframammary region, 
measuring 25 × 20 mm (Figure 4). On palpation, the lesion 
was indurated and tender and resembled a morphea plaque. 
Dermoscopy revealed a pigmented network, with areas with 
interruptions in the network, over a pinkish background. No 
vascular structures were visible (Figure 5, A and B). A 5-mm 
punch biopsy was performed. Histopathological examination 
revealed a storiform pattern of a dermal spindle cell prolifera-
tion infiltrating the subcutaneous fat tissue in a honeycomb 
pattern (Figure 6A). Immunohistochemistry using anti-CD34 
scopic aspects of DFSP and its variants [3-11]. In this article, 
we present 2 cases of DFSP and their dermoscopic features, as 
well as a review of previously published dermoscopic descrip-
tions of this rare neoplasm.
Case Reports
Patient 1
A 73-year-old woman, Fitzpatrick skin phototype III, pre-
sented with a 5-year history of an asymptomatic, slowly 
enlarging, nodular lesion located on the abdomen. Physical 
examination showed a solitary mesogastric erythematous 
tumor measuring 80 × 80 mm (Figure 1). On palpation, the 
lesion was firm and not tender. Dermoscopy revealed fine 
arborizing telangiectasias and linear vessels over structureless 
depigmented areas, surrounded by a pink background with 
unfocused vessels (Figure 2, A and B). A 5-mm punch biopsy 
was performed. Histopathological examination revealed 
spindle-shaped tumor cells in a storiform pattern (Figure 
3, A and B), suggesting DFSP. The diagnosis was confirmed 
by immunohistochemistry, with positive staining using anti-
CD34 antibody (Figure 3C). Magnetic resonance imaging 
showed a homogeneous nodular lesion circumscribed to the 
subcutaneous tissue and a chest x-ray ruled out lung metas-
Figure  1.  Erythematous tumor located on 
the abdomen. An ecchymotic hue post-biop-
sy could be visualized. [Copyright: ©2019 
Escobar et al.]
Figure 3. (A) Spindle-shaped cells arranged in a storiform pattern (H&E, ×100). (B) (H&E, ×400). (C) Immunohistochemistry using anti-
CD34 antibody revealed that spindle cells were positive. H&E = hematoxylin and eosin. [Copyright: ©2019 Escobar et al.]
A B C
Figure 2. (A) Fine arborizing telangiectasias and linear vessels over structureless depigment-
ed areas, surrounded by a pink background with unfocused vessels (×20). (B) Close-up to 
visualize the central vascular structures (×50). [Copyright: ©2019 Escobar et al.]
A B
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(PDGFB) signaling pathway plays a central role in the prolif-
eration of DFSP tumor cells [2]. The typical histopathological 
characteristics of DFSP are described as uniform spindle cells 
with elongated nuclei, showing minimal atypia or mitotic 
activity, resulting in a storiform pattern [2,12]. The tumor 
infiltrates into the subcutaneous tissue, creating the charac-
teristic honeycomb pattern. Other spindle cell tumors such 
as dermatofibroma, malignant fibrous histiocytoma, atypical 
fibroxanthoma, desmoplastic melanoma, Kaposi sarcoma, 
and solitary fibrous tumor are the histological differential 
diagnoses [2,12]. The infiltrative pattern of DFSP helps to 
differentiate it from benign entities, even though it is usu-
ally not sufficient for a conclusive diagnosis. In these cases, 
immunohistochemistry becomes a useful resource, since DFSP 
reveals positivity for CD34 and negativity for S100 protein, 
factor XIIIA, and desmin [1,2]. Histological variants of DFSP 
have been described in the literature, such as the pigmented 
variant (Bednar tumor), myxoid DFSP, juvenile form (giant 
cell fibroblastoma), fibrosarcomatous variant, sclerosing 
DFSP, and atrophic subtype [16,17].
Dermoscopic findings of DFSP are limited in the literature 
[3-11]. We performed an extensive search in the PubMed 
database and found a total of 9 articles with 30 patients 
(Table 1). The first report, conducted by Bernard et al [3], 
antibody revealed that spindle cells were positive, confirm-
ing the diagnosis of DFSP (Figure 6B). The lesion was totally 
excised with margins of 4 cm and there has been no recur-
rence in 2 years of follow-up.
Discussion
DFSP is a slowly growing mesenchymal neoplasm, charac-
terized by high morbidity due to its local invasion and high 
recurrence rate after surgical excision [12,13]. The peak age 
at onset is between 20 and 50 years, and incidence among 
women is 1.14 times higher than in men [14]. The tumor 
usually presents as a slowly growing, painless, reddish brown 
nodule or plaque. The trunk is the most common anatomic 
site, followed by proximal extremities [1,15]. Furthermore, 
DFSP may present as a morphea-like, atrophic, sclerotic, vio-
laceous plaque that may ulcerate as it gradually increases in 
size [2,11]. The main differential diagnoses include cutaneous 
melanoma and dermatological manifestations of metastatic 
carcinomas. Also, DFSP may mimic benign lesions such as 
dermatofibromas, hypertrophic scars, and keloids [2,9,11].
A chromosome translocation is found in more than 90% 
of the cases, involving chromosomes 17q22 and 22q13 [1,2]. 
The constitutively activated platelet-derived growth factor-β 
Figure 4. Brown atrophic plaque on the left inframammary region. 
[Copyright: ©2019 Escobar et al.]
Figure 6.  (A) Spindle-shaped 
cells  arranged in a  storiform 
pattern (H&E, ×100). (B) Im-
munohistochemistry using anti-
CD34 antibody revealed that 
spindle cells were positive. H&E 
= hematoxylin and eosin. [Copy-
right: ©2019 Escobar et al.]
A B
Figure 5. (A,B) Pigmented network, with areas with interruptions 
in the network, over a pinkish background. No vascular structures 
were visible (×20). [Copyright: ©2019 Escobar et al.]
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Furthermore, Hartmann et al [8] described a case of DFSP 
with clinical and dermoscopic features that resembled a basal 
cell carcinoma. In this case, dermoscopy showed 2 criteria 
used to diagnose basal cell carcinoma: arborizing telangiec-
tasias and structures similar to blue-gray ovoid nests. In addi-
tion, hypopigmented areas, light brown pigment network, 
and pale pink areas could also be visualized. DFSP may also 
resemble keloids, particularly in patients with darker skin. 
Piccolo et al [9] described the case of an African male patient 
with the following dermoscopic features: atypical network, 
structureless hyper- and hypopigmented areas, shiny white 
streaks, and unfocused linear-irregular vessels. This report 
also highlights the dermoscopic multicomponent pattern, 
which should always raise a red flag for malignancy.
Recurrent DFSP may be very challenging to diagnose 
because it can resemble scar tissue. Venturini et al [10] 
reported 1 case in which they observed linear white and pink 
areas surrounded by structureless light brown areas with 
focal pigmented reticular lines. These findings were similar to 
those described by Bernard et al [3]. This article included 2 
recurrent lesions and the authors did not identify differences 
between the dermoscopic patterns observed in patients with 
recurrent DFSP and those with primary lesions.
Recently, Costa et al [11] analyzed dermoscopic findings 
in 5 clinical variants of DFSP (however, 1 was previously 
described [9]). The angioma-like DFSP displayed thick arbo-
rizing vessels arranged in a centrifugal fashion on a pinkish 
background. Also presenting with vascular structures, the 
keloid-like DFSP had polymorphic vessels (linear and arboriz-
ing) on a white-to-bluish background and structureless white 
areas. Moreover, a morphea-like plaque DFSP was reported, 
exhibiting a slightly pigmented network, structures, and linear 
vessels. However, nodule-plaque morphea-like DFSP pre-
sented with a pigmented network, arborizing thin vessels, and 
hypopigmented unstructured areas on a pinkish background 
in the plaque area, while the nodular portion exhibited a dot-
ted vascular pattern and white streaks.
Regarding our cases presented in this report, patient 1 
exhibited the multicomponent pattern described by Bernard 
et al [3]. In this case, fine arborizing telangiectasias and 
linear vessels could be seen over structureless depigmented 
areas, which were surrounded by a pinkish background 
with unfocused vessels. Despite the fact that a pigmented 
network was reported in 87% of the lesions [3], in patient 
1 there were no pigmented structures. Of interest, in patient 
2 the only dermoscopic findings were a pigmented network 
with a pinkish background and no vessels could be observed. 
Although this case clinically had a morphea-like aspect, 
our dermoscopic features differed from those described by 
Costa et al [11] in their morphea-like variant in that we did 
not observe hypopigmented structures or vessels. Therefore, 
analyzed 15 cases of DFSP, including 1 case of Bednar tumor. 
In this study, 80% of the lesions were located on the trunk, 
while the remaining were on the upper limbs. In this article, 
6 dermoscopic characteristics and their frequency were 
described: delicate pigmented network (87%), vessels (80%), 
structureless light brown areas (73%), shiny white streaks 
(67%), pink background coloration (67%), and structureless 
hypo- or depigmented areas (60%). Among the lesions with 
vessels, all had unfocused vessels and half had a mixture of 
unfocused and focused vessels. Arborizing vessels were the 
most prevalent vascular structure, since it was found in 11 
of 12 cases. Therefore, the authors concluded that the most 
common dermoscopic pattern observed was the coexistence 
of reticular pigmentation and unfocused and/or focused 
arborizing vessels. Another interesting finding was the high 
number of dermoscopic features per lesion (a median of 4), 
also called a multicomponent pattern, which is suggestive of 
malignant tumors [3,18,19].
Subsequently, Avilés-Izquierdo et al [4] described the 
dermoscopic features in 4 cases of DFSP. All lesions consisted 
of plaques, located mainly on the trunk (75%). The most 
prominent dermoscopic features observed by the authors 
were mesh-like vessels, mostly located peripherally, which his-
tologically corresponded to dilated vessels in the superficial 
dermis. In addition, all cases presented with a fine pigment 
network, histologically represented by hyperpigmentation 
in the basal cell layer. Milky red areas were observed in 3 
cases, as well as whitish linear structures or areas, which 
histologically corresponded to intersecting bands of tumor 
cells in the dermis, forming a storiform pattern. Esdaile et al 
[5] also described a similar case with a fine pigment network 
over a pink background, with structureless hypo- and hyper-
pigmented areas and nonspecific vessels.
A further report by Güngör et al [6] described 1 case of 
the atrophic variant of DFSP. In this patient, dermoscopic 
examination revealed arborizing telangiectasias and a yel-
lowish background. The authors suggested that this par-
ticular background coloration could be explained by dermal 
atrophy and the close approximation of the subcutis to the 
epidermis. In addition, Ehara et al [7] described 1 case of the 
pigmented variant of DFSP (Bednar tumor), which clinically 
and dermoscopically mimicked a blue nevus. In this case, 
a homogeneous black-bluish pigmentation with white-veil 
structures was observed, while no vessels could be visualized. 
While the diffuse and intense pigmentation was attributed to 
melanin-laden spindle cells in the dermis and subcutaneous 
tissue, the white veil structures corresponded to collagen in 
the upper dermis. Since the tumor had a deeper presentation, 
no vascular structures could be appreciated, which differed 
from the Bednar case reported by Bernard et al, which dis-
played vessels on dermoscopy [3].
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corroborate the earlier findings of most studies [3-,5,9-11]; 
however, atypical dermoscopic presentations have also been 
described [6-8]. Since this tumor may mimic benign lesions, 
dermoscopy is a valuable tool, indicating the need for a 
prompt biopsy and contributing to the correct diagnosis.
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even in the same DSFP clinical variant, the dermoscopic 
features may vary.
In the attempt to summarize previously published data 
with the 2 new cases presented in this report (Table 2), we 
found that the 3 most common dermoscopic findings were 
the presence of vessels (81%), followed by a pigmented 
network (78%) and a pinkish background (66%). Vascular 
structures included arborizing, mesh-like, linear-irregular, 
or polymorphic vessels. In relation to the pigment network 
observed, it corresponds to the increased pigment in the 
epidermal basal cells, rather than melanocytic proliferation. 
Therefore, it is an exception to the rule that the presence of 
a pigment network is a dermoscopic clue for the diagnosis of 
a melanocytic lesion [18].
Furthermore, 50% displayed structureless hypo- or depig-
mented areas and 44% presented structureless light brown 
areas. Shiny white streaks, which were observed in more 
than half of the cases (53%), may have been underestimated 
since this finding is only seen under polarized dermoscopy 
[20]. Unfortunately, not all previous studies described the 
dermoscopic acquisition method. This is an interesting issue 
to evaluate in future cases, since shiny white streaks have 
been related to malignant neoplasms, such as melanomas 
and basal cell carcinomas [20] and, therefore, could also be 
an indicator of DFSP.
Surgical excision remains the mainstay treatment for 
DFSP. Because of its infiltrating growth pattern, a wide exci-
sion with margins of at least 3 cm of clinically uninvolved 
skin is strongly advised for the treatment of DFSP [13,21,22]. 
Alternatively, Mohs micrographic surgery has become the 
treatment of choice for most skin cancers on the head and 
neck, as well as for recurrent or histologically aggressive 
lesions [1,12,23]. Adjuvant radiotherapy may be indicated 
when the resection margins are positive or when excision 
may result in significant aesthetic or functional damage [21]. 
Based on the knowledge about the signaling mechanisms of 
tumor proliferation, imatinib mesylate has shown significant 
therapeutic value in the treatment of DFSP [1,12]. Further-
more, predictors of poorer overall survival include older age 
at diagnosis, male sex, and large tumor size [15]. In addi-
tion, the pathological fibrosarcomatous variant is associated 
with an aggressive clinical course, with a higher rate of local 
recurrence and metastasis [24]. Since recurrences usually 
occur within 3 years of primary excision, patients should be 
followed up every 6 months during this period and annually 
thereafter [21].
Conclusions
This current report illustrates dermoscopic features of 2 cases 
of DFSP, as well as a review of previous reports. Our findings 
Table 2. Most Common Dermoscopic Findings of 
DFSP and Their Frequency (Total of 32 Cases)
Dermoscopic Featuresa Frequency (n)
Pigmented network 78% (25)
Vessels 81% (26)
Structureless light brown areas 44% (14)
Shiny white streaks 53% (17)
Pink background 66% (21)
Structureless hypo- or 
depigmented areas
50% (16)
aBernard et al [3].
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